Protalix Biotherapeutics Inc (PLX)
Working Capital Ratio
55.13%
Quarterly · Period ending:
PLX Working Capital Ratio
Latest reported48.76%period ending
Latest reported48.76%period ending
PLX FY Working Capital Ratio (98.80% → 48.76%)
Annual working capital ratio
High-resolution chart · PNG
PLX working capital ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 48.7638% | |
| 46.9333% | |
| 28.9007% | |
| 22.3188% | |
| 38.6751% | |
| -45.266% | |
| -16.9545% | |
| 45.198% | |
| 55.2511% | |
| 6.8756% | |
| 76.7544% | |
| 50.0956% | |
| 62.8299% | |
| 44.9846% | |
| 26.6345% | |
| 42.3767% | |
| 62.7135% | |
| 74.5154% | |
| 87.1846% | |
| 81.6029% | |
| 92.6136% | |
| 87.5452% | |
| 89.2649% | |
| 86.0227% | |
| 85.8938% | |
| 65.0338% | |
| 57.8302% | |
| 25.4829% | |
| 98.2581% | |
| 98.7952% |